RELATED EXPERIENCE

(LONDON) 08 December, 2014 – International law firm Brown Rudnick LLP has advised Midatech Pharma, a nanomedicine company, on its admission to AIM and acquisition of Q Chip Limited, a drug delivery company.

Midatech Pharma develops and commercialises therapeutic products to enhance the delivery of medicines for diseases with high unmet medical needs such as cancer and diabetes and has acquired Q Chip Limited upon its admission to AIM on 8 December. Q Chip Limited is a specialist drug delivery company focused on the application of fluidic droplet systems.

Tim Matthews was the lead Partner for Brown Rudnick in a flotation that is noteworthy for its short timeframe and a simultaneous IPO and acquisition, as well as the cross-border complexity provided by a US-based major shareholder in Midatech.

Midatech hopes to take advantage of a resurgent appetite for medical research companies in the City to join the AIM.

The flotation will enable Midatech to rapidly move ahead with clinical trials for joint ventured products for the treatment of diabetes, to fund the pre-clinical and clinical development of brain, liver and pancreatic cancer treatments and to accelerate product programmes based on acquired sustained release technology.

Tim Matthews, Partner in Brown Rudnick’s Corporate practice, said: “The simultaneous IPO and acquisition makes this listing noteworthy, as well as the cross-border complexity provided by a US-based major shareholder in Midatech.”

Panmure Gordon (UK) Limited is acting as nominated adviser and broker to Midatech.

 * * *

For further information, please contact:

Dragon Associates
George Morrison / Claire Rumbellow
T: +44 (0)20.7495.4401
E: george.morrisson@dragonassocs.com / claire.rumbellow@dragonassocs.com

About Brown Rudnick LLP

Brown Rudnick, an international law firm with offices in the United States and Europe, represents clients from around the world in high-stakes litigation, international arbitration and complex business transactions. Clients include public and private corporations, multinational Fortune 100 businesses and start-up enterprises. The Firm also represents investors, as well as official and ad hoc creditors’ committees in today’s largest corporate restructurings, both domestically and abroad. Founded more than 60 years ago, Brown Rudnick has over 230 lawyers providing advice and services across key areas of the law. Beyond the United States, the Firm regularly serves clients in Europe, the Middle East, North Africa, the Caribbean and Latin America. With its Brown Rudnick Center for the Public Interest, the Firm has created an innovative model combining its pro bono, charitable giving and community volunteer efforts.